Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say

How did the Musk-Trump feud impact Tesla's stock? Why did Bitcoin face a $1B liquidation recently? What caused Lululemon’s stock to plunge? How do tariffs affect US retail businesses now? What’s behind the Federal Reserve's current rate stance? How will Trump’s new drone orders affect US airspace? Why is Tesla’s humanoid robot lead leaving?

Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say

benzinga.com/markets/large-cap/25/06/45814068/novo-nordisks-wegovy-tied-to-increased-risk-of-rare-vision-loss-disorder-european-regulators-sa

The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns regarding a possible increased risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), an eye condition that may cause vision…

This story appeared on benzinga.com, 2025-06-06 13:48:30.